TG Therapeutics, Inc. (TGTX) Profit Margin
TG Therapeutics, Inc. (TGTX) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | -51353.45% |
| 2017-12-31 | -77944.74% |
| 2018-12-31 | -114132.89% |
| 2019-12-31 | -113730.92% |
| 2020-12-31 | -183803.29% |
| 2021-12-31 | -5204.08% |
| 2022-12-31 | -7121.54% |
| 2023-12-31 | 5.42% |
| 2024-12-31 | 7.11% |
| 2025-12-31 | 72.56% |
How TGTX compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| BMRN | BioMarin Pharmaceutical Inc. | 10.83% |
| IQV | IQVIA Holdings Inc. | 8.34% |
| ENSG | The Ensign Group Inc. | 6.80% |
| VCEL | Vericel Corporation | 5.98% |
| PAHC | Phibro Animal Health Corporation | 3.72% |
These are five companies in the same sector as TGTX with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get TG Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("TGTX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TGTX | $55.98 | -1.28% | 0.99M |
| 3 | ||||
| 4 | ||||
| 5 |